You can be on the frontier of biomedical science during Team Science Day on Sept. 16 in New York City. Join us as we convene leaders across the public and private sectors, academia, and patient advocacy groups to discover what it will take to achieve tomorrow’s breakthroughs.
Learn about sponsorship opportunities.
Help us promote this event with the Team Science Day Social Toolkit.
Agenda
Breakfast and Registration, 8:00 AM-9:00 AM
Building Bridges to Breakthroughs, 9:00 AM-9:20 AM – Julie Gerberding, President and Chief Executive Officer, FNIH
Fireside Chat, 9:20 AM-9:50 AM
- Diana Bianchi, Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Julie Gerberding, President and Chief Executive Officer, FNIH
- Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke (NINDS)
- Joni Rutter, Director, National Center for Advancing Translational Sciences (NCATS)
Accelerating Medicines Partnership® for ALS, 9:50 AM-10:30 AM
- Joseph P. Menetski (moderator), Senior Vice President, Chief Translational Science Officer, FNIH
- Stephanie Fradette, Vice President, Head of Neuromuscular Development Unit, Biogen
- Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke (NINDS)
- Dave Shulman, Patient Advocate
- Alessio Travaglia, Director, Neuroscience, FNIH
Break, 10:30 AM
How AI is Transforming Healthcare, 10:50 AM-11:20 AM
- Jim Weiss (moderator), Chairman and Founder, Real Chemistry
- Brian Anderson, Chief Executive Officer and Co-Founder, Coalition for Healthcare AI (CHAI)
- Luca Foschini, President and Chief Executive Officer, Sage Bionetworks
- Jessica Liao, Principal Product Manager, Microsoft
Clinical Trial Innovation at Scale, 11:20 AM-12:00 PM
- Monica Bertagnolli, Director, National Institutes of Health (NIH), live via webcast
- Julie Gerberding, President and Chief Executive Officer, FNIH
- Hilary Marston, Chief Medical Officer, Food and Drug Administration (FDA)
Lunch with FNIH Experts, 12:00 PM-1:00 PM
- Stacey Adam, Vice President, Science Partnerships, Translational Science
- David Carmel, Senior Vice President, Chief Growth and Innovation Officer
- Love Collins III, Vice President of Advancement
- Steven Hoffmann, Vice President, Science Partnerships, Translational Science
- Tania Kamphaus, Associate Vice President, Science Partnerships and Director of Patient Engagement
- Michael Santos, Senior Vice President, Chief Population Health Science Officer
- Alessio Travaglia, Director, Neuroscience
The Future of Health in the Era of Obesity Treatments, 1:00 PM-1:45 PM
- Nina Kjellson (moderator), General Partner, Canaan Partners
- Javed Butler, Senior Vice President, Baylor Scott and White Health (BSWH)
- Joe Nadglowski, President and Chief Executive Officer, Obesity Action Coalition
- Mark Pruzanski, Former CEO, Versanis Bio
- Melissa Thomas, Vice President, Diabetes, Obesity, and Cardiometabolic Research, Lilly Research Laboratories
Precision Oncology: From Treatment to Cure, 1:45 PM-2:15 PM
- Stacey Adam (moderator), Vice President, Science Partnerships, Translational Science, FNIH
- Irene Ghobrial, Senior Vice President for Experimental Medicine, Professor of Medicine, Dana-Farber Cancer Institute
- Roy Herbst, Professor of Medicine, Chief of Medical Oncology, Yale School of Medicine
- Rochelle Prosser, Founder, Orchid Healthcare Solutions
- Karen Reckamp, Professor in Medicine, Director of the Division of Medical Oncology, Cedars Sinai
Celebrating Scientists as Stars, 2:15 PM-2:45 PM
- Steven M . Paul (moderator), Chairman, Board of Directors, FNIH
- Christopher Bartley, Chief, Translational Immunopsychiatry Unit, National Institute of Mental Health; 2021 Deeda Blair Research Initiative Award Recipient
- Nikhil Wagle, Vice President and Global Head of Translational Medicine at Genentech; 2022 Trailblazer Prize for Clinician-Scientists Award Recipient
Decoding Depression: Predicting Outcomes in Mental Health, 2:45 PM-3:15 PM
- Joseph P. Menetski (moderator), Senior Vice President, Chief Translational Science Officer, FNIH
- Amit Etkin, Chief Executive Officer and Founder, Alto Neuroscience
- Katherine Burdick, Associate Vice Chair for Research, Department of Psychiatry, Brigham and Women’s Hospital
- Conor Liston, Professor of Psychiatry, Weill Cornell Medical College
- Brian Michel, Associate VP of Foundations and Government Relations, Mental Health America
- Lynne Zydowsky, Chief Science Officer, Alexandria Real Estate Equities, Inc.
Break, 3:15 PM
New Models for Rare Disease Drug Development, 3:35 PM-4:05 PM
- Courtney Silverthorn (moderator), Vice President, Strategic Alliances and Innovation, FNIH
- Joni Rutter, Director, National Center for Advancing Translational Sciences (NCATS)
- Iwona Jeske DuPont, Vice President, Rare Disease, Pfizer
- Hilary Marston, Chief Medical Officer, Food and Drug Administration (FDA)
- Pamela Gavin, Chief Executive Officer, National Organization for Rare Disorders
A Transformative Time for Women’s Health, 4:05 PM-4:50 PM
- Michael Santos, Senior Vice President, Chief Population Health Science Officer, FNIH
- Diana Bianchi, Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Ru-fong Joanne Cheng, Director, Women’s Health Innovations, Bill & Melinda Gates Foundation
- Jessica Federer, Independent Board Member
- Kima Tozay, Patient Advocate
Closing Remarks, 4:50 PM-5:00 PM – Julie Gerberding
Reception, 5:00 PM
Team Science Day is made possible through the generosity of our sponsors:
